Mega Lifesciences PCL
SET:MEGA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
33.5
44
|
| Price Target |
|
We'll email you a reminder when the closing price reaches THB.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Mega Lifesciences PCL
Income from Continuing Operations
Mega Lifesciences PCL
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mega Lifesciences PCL
SET:MEGA
|
Income from Continuing Operations
฿1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
10%
|
CAGR 10-Years
15%
|
|
|
B
|
Bangkok Lab and Cosmetic PCL
SET:BLC
|
Income from Continuing Operations
฿150.8m
|
CAGR 3-Years
122%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
|
Mega Lifesciences PCL
Glance View
Mega Lifesciences Public Co. Ltd. engages in the manufacture, market, sale, and distribution of pharmaceutical, nutraceutical products, and consumer goods. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2013-11-19. The firm's products include complimentary medicines, over-the-counter (OTC) medicines and prescription medicines to both domestic and international markets. The company distributes products under Maxxcare brand covering prescription pharmaceutical products, OTC drugs and other consumer products. The firm also offers nutritional products, prescription pharmaceutical products and OTC drugs under Mega We Care brand. In addition, the Company operates as an original equipment manufacturer (OEM) for various products including health supplements, pharmaceutical, herbal products, vitamins and minerals, among others.
See Also
What is Mega Lifesciences PCL's Income from Continuing Operations?
Income from Continuing Operations
1.8B
THB
Based on the financial report for Sep 30, 2024, Mega Lifesciences PCL's Income from Continuing Operations amounts to 1.8B THB.
What is Mega Lifesciences PCL's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
15%
Over the last year, the Income from Continuing Operations growth was -4%.
You don't have any saved screeners yet
